sEV-Enriched Serum Preparations From Healthy Individuals Protect Against Acute Pancreatitis-Induced Intestinal Barrier Dysfunction Through miR-579-3p/ANXA3-Mediated Inhibition of NLRP3 Inflammasome Pyroptosis
Archivum Immunologiae et Therapiae Experimentalis · 01.01.2026 · 74 (1)
DOI: 10.2478/aite-2026-0018 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archivum Immunologiae et Therapiae Experimentalis, online erschienen am 25.06.2026. Verfasst von Huiyuan Gu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu Province 215006, China. Hauptthemen laut MEDLINE: Pancreatitis, MicroRNAs, NLR Family, Pyrin Domain-Containing 3 Protein, Inflammasomes. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Acute pancreatitis (AP) frequently triggers intestinal barrier dysfunction, yet the underlying molecular mechanisms remain poorly understood. This study investigated whether small extracellular vesicle (sEV)-enriched serum preparations from healthy individuals protect against AP-induced intestinal barrier dysfunction through microRNA-mediated regulation of pyroptosis. sEV-enriched preparations were isolated from 10 AP patients (AP-sEV) and 10 healthy controls (HC-sEV) using ExoQuick precipitation followed by ultracentrifugation. A murine AP model was established using cerulein and lipopolysaccharide, and human intestinal epithelial cells were stimulated with lipopolysaccharide for in vitro studies. HC-sEV preparations significantly ameliorated AP-induced tissue damage, restored tight junction proteins (claudin-1, occludin, ZO-1), reduced intestinal permeability, and suppressed inflammatory cytokines (TNF-α, IL-6, IL-1β) and pyroptosis-related proteins including NLRP3, gasdermin D, and cleaved caspase-1. Conversely, AP-sEV preparations exacerbated barrier dysfunction. Bioinformatics analysis identified miR-579-3p as significantly downregulated in AP-sEV. Inhibition of miR-579-3p reversed HC-sEV protective effects. ANXA3 was validated as a direct miR-579-3p target, and ANXA3 overexpression counteracted miR-579-3p-mediated protection. These findings demonstrate that HC-sEV preparations protect against AP-induced intestinal barrier dysfunction through miR-579-3p delivery targeting ANXA3 to suppress NLRP3 inflammasome-mediated pyroptosis. The miR-579-3p/ANXA3/NLRP3 axis represents a novel therapeutic target for preserving intestinal barrier integrity during acute pancreatitis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu Province 215006, China.
Zitieren
APA
Gu, H., Tang, C., Shi, Y., Shen, J., & Xu, C. (2026). sEV-Enriched Serum Preparations From Healthy Individuals Protect Against Acute Pancreatitis-Induced Intestinal Barrier Dysfunction Through miR-579-3p/ANXA3-Mediated Inhibition of NLRP3 Inflammasome Pyroptosis. Archivum Immunologiae et Therapiae Experimentalis, 74(1). https://doi.org/10.2478/aite-2026-0018
Vancouver
Gu H, Tang C, Shi Y, Shen J, Xu C. sEV-Enriched Serum Preparations From Healthy Individuals Protect Against Acute Pancreatitis-Induced Intestinal Barrier Dysfunction Through miR-579-3p/ANXA3-Mediated Inhibition of NLRP3 Inflammasome Pyroptosis. Archivum Immunologiae et Therapiae Experimentalis. 2026;74(1). doi:10.2478/aite-2026-0018
BibTeX
@article{Gu2026,
author = {Gu, Huiyuan and Tang, Chenyue and Shi, Yuqi and Shen, Jiaqing and Xu, Chunfang},
title = {sEV-Enriched Serum Preparations From Healthy Individuals Protect Against Acute Pancreatitis-Induced Intestinal Barrier Dysfunction Through miR-579-3p/ANXA3-Mediated Inhibition of NLRP3 Inflammasome Pyroptosis},
journal = {Archivum Immunologiae et Therapiae Experimentalis},
year = {2026},
volume = {74},
number = {1},
doi = {10.2478/aite-2026-0018}
}
EUVIMED